Search hospitals > Michigan > Detroit

Henry Ford Hospital

Claim this profile
Detroit, Michigan 48202
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Brain Tumor
Conducts research for Pancreatic Cancer
1851 reported clinical trials
105 medical researchers
Photo of Henry Ford Hospital in DetroitPhoto of Henry Ford Hospital in DetroitPhoto of Henry Ford Hospital in Detroit

Summary

Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Brain Tumor, Pancreatic Cancer and other specialties. Henry Ford Hospital is involved with conducting 1,851 clinical trials across 1,550 conditions. There are 105 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Shirish Gadgeel, MD, and Eleanor M. Walker.

Area of expertise

1

Lung Cancer

Global Leader

Henry Ford Hospital has run 178 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Breast Cancer

Global Leader

Henry Ford Hospital has run 131 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
Stage III

Top PIs

Clinical Trials running at Henry Ford Hospital

Breast Cancer

Lung Cancer

Breast cancer

Pancreatic Cancer

Cancer

Multiple Sclerosis

Asthma

Melanoma

Brain Tumor

Multiple Myeloma

Image of trial facility.

Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib

for Breast Cancer

The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.

Recruiting

2 awards

Phase 3

12 criteria

Image of trial facility.

Gedatolisib Combination

for Breast Cancer

This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant and CDK4/6 Inhibitors for the treatment of patients with locally advanced or metastatic HR+/HER2- advanced breast cancer.

Recruiting

2 awards

Phase 3

6 criteria

Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Recruiting

2 awards

Phase 3

6 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Henry Ford Hospital?

Where is Henry Ford Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Henry Ford Hospital accept?

What awards or recognition has Henry Ford Hospital received?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security